Protalys Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $18.7M

  • Investors
  • 1

Protalys Therapeutics General Information

Description

Developer of a therapeutic delivery technology intended to improve the performance of targeted protein degradation agents. The company employs established in situ carriers to transport small-molecule degraders into solid tumors, enhancing pharmacokinetics, addressing limitations of difficult targets, enabling the rescue of previously ineffective degraders, and supporting expanded discovery opportunities in oncology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Diego, CA
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Corporate Office
  • San Diego, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Protalys Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Aug-2025 $18.7M Completed Startup
To view Protalys Therapeutics’s complete valuation and funding history, request access »

Protalys Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Protalys Therapeutics’s complete cap table history, request access »

Protalys Therapeutics Patents

Protalys Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026136975-A1 Albumin binder conjugated protac degraders and uses thereof Pending 20-Dec-2024

Protalys Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avalon Bioventures Venture Capital Minority
To view Protalys Therapeutics’s complete investors history, request access »

Protalys Therapeutics FAQs

  • Where is Protalys Therapeutics headquartered?

    Protalys Therapeutics is headquartered in San Diego, CA.

  • What industry is Protalys Therapeutics in?

    Protalys Therapeutics’s primary industry is Biotechnology.

  • Is Protalys Therapeutics a private or public company?

    Protalys Therapeutics is a Private company.

  • What is the current valuation of Protalys Therapeutics?

    The current valuation of Protalys Therapeutics is .

  • What is Protalys Therapeutics’s current revenue?

    The current revenue for Protalys Therapeutics is .

  • How much funding has Protalys Therapeutics raised over time?

    Protalys Therapeutics has raised $18.7M.

  • Who are Protalys Therapeutics’s investors?

    Avalon Bioventures has invested in Protalys Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process